Supply of 780,000 Government Stockpiled Antiviral Drugs Including Tamiflu... "Response to Influenza Outbreak"

Tamiflu stock photo.

[Asia Economy Reporter Lee Gwanju] The Korea Disease Control and Prevention Agency announced on the 6th that it will sequentially supply government stockpiled antiviral drugs, including Tamiflu, to the market starting next week to cope with the winter influenza (flu) outbreak.

During the 2017-2018 influenza outbreak period, the market supply volume itself was 2 million doses, but the current pharmaceutical companies' inventory is estimated to be about 1.25 million doses. Accordingly, the KDCA explained that it decided to supply the government stockpiled quantity to cover the shortage.

The current government stockpiled antiviral drugs amount to 12.92 million doses. The KDCA plans to immediately supply 787,000 doses and provide additional supplies if necessary.

Ji Youngmi, head of the KDCA, said, "With the supply of government stockpiled antiviral drugs this time, we hope that patients can take antiviral drugs in a timely manner," adding, "The antiviral drugs supplied to the market will later be replenished with equivalent medicines from pharmaceutical companies to ensure proper management of the government's stockpiled supplies."

This content was produced with the assistance of AI translation services.